XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 20,375 $ 349,172
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 24,168 20,369
Loss (gain) on derivative instruments (7,258) 4,371
Cash settlements (paid) received on expired derivative instruments 13,564 (5,082)
Cash settlements received (paid) on terminated derivative instruments 793 658
Deferred income tax expense (benefit) 3,082 (264,130)
Accretion of asset retirement obligations 6,282 5,922
Share-based compensation (see Note 10) 5,113 3,608
Settlement of asset retirement obligations (750) (993)
Amortization and write-off of deferred financing costs 918 1,679
Bad debt expense 52 98
Changes in operating assets and liabilities:    
Accounts receivable 6,749 32,493
Prepaid expenses and other assets (2,798) (3,844)
Payables and accrued liabilities (31,452) (28,459)
Other   (2,634)
Net cash provided by operating activities 38,838 113,228
Cash flows from investing activities:    
Additions to oil and gas properties (54,102) (23,065)
Additions to other property and equipment (1,037) (501)
Additions to restricted investments (7,516) (6,399)
Net cash used in investing activities (62,655) (29,965)
Cash flows from financing activities:    
Advances on Revolving Credit Facility 85,000 125,000
Payments on Revolving Credit Facility (80,000) (195,000)
Deferred financing costs (76) (4,698)
Shares withheld for taxes (1,853) (2,178)
Net cash used in financing activities 3,071 (76,876)
Net change in cash and cash equivalents (20,746) 6,387
Cash and cash equivalents, beginning of period $ 20,746  
Cash and cash equivalents, end of period   $ 6,387